Hybrisan Overview
- Year Founded
-
2013
- Status
-
Acquired/Merged
- Employees
-
3
- Latest Deal Type
-
M&A
Hybrisan General Information
Description
Developer of medical technologies designed for the treatment of chronic wounds and infection control. The company's platform utilizes electrospinning and antimicrobial formulations to produce irrigation and nanofibre materials, enabling healthcare providers to disrupt biofilms and manage bioburden in acute and chronic wound care.
Contact Information
Website
www.hybrisan.com(Operating Subsidiary)
Corporate Office
- Unit 2 Cramic Way
- Port Talbot SA13 1RU
- Wales, United Kingdom
Corporate Office
- Unit 2 Cramic Way
- Port Talbot SA13 1RU
- Wales, United Kingdom
Hybrisan Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Merger/Acquisition | 05-Jun-2026 | Completed | Generating Revenue | |||
| 3. Grant | 01-Oct-2022 | Completed | Generating Revenue | |||
| 2. Grant | 01-Jun-2020 | $60.6K | $618K | Completed | Generating Revenue | |
| 1. Angel (individual) | 19-May-2020 | $618K | $618K | Completed | Generating Revenue |
Hybrisan Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Hybrisan Patents
Hybrisan Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-2627097-B | Antimicrobial composition for use in treating a wound infection | Active | 13-Oct-2021 | ||
| CA-3234661-A1 | Composition | Pending | 13-Oct-2021 | ||
| EP-4415681-A1 | Composition | Pending | 13-Oct-2021 | ||
| GB-202114628-D0 | Composition | Inactive | 13-Oct-2021 | ||
| GB-202406302-D0 | Composition | Active | 13-Oct-2021 | A61K31/695 |
Hybrisan Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Hybrisan Former Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Development Bank of Wales | Growth/Expansion | Minority | ||
| Innovate UK | Government | |||
| Welsh Government | Government |
Hybrisan FAQs
-
When was Hybrisan founded?
Hybrisan was founded in 2013.
-
Where is Hybrisan headquartered?
Hybrisan is headquartered in Port Talbot, United Kingdom.
-
What is the size of Hybrisan?
Hybrisan has 3 total employees.
-
What industry is Hybrisan in?
Hybrisan’s primary industry is Biotechnology.
-
Is Hybrisan a private or public company?
Hybrisan is a Private company.
-
What is Hybrisan’s current revenue?
The current revenue for Hybrisan is .
-
How much funding has Hybrisan raised over time?
Hybrisan has raised $618K.
-
Who are Hybrisan’s investors?
Development Bank of Wales, Innovate UK, and Welsh Government have invested in Hybrisan.
-
When was Hybrisan acquired?
Hybrisan was acquired on 05-Jun-2026.
-
Who acquired Hybrisan?
Hybrisan was acquired by Eumar Technology.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
